REMEDY : BNSSG referral pathways & Joint Formulary


Home > Adults > COVID-19 >

TeamNet and Latest updates

Checked: 22-02-2023 by Rob Adams Next Review: 22-02-2024

Primary Care Advice

A single source of information for General Practice

BNSSG ICB, the Avon Local Medical Committee and One Care are working together to ensure that our colleagues in General Practice have access to the latest COVID-19 information and updates all in one place. TeamNet is the ‘go to’ place for the latest national guidance, as well as ICB, LMC and One Care updates, templates and resources.

We are also setting up a WhatsApp broadcast group, which means we can message you with any important changes or developments. We are adding all practice manager mobile numbers to the group, and you will be able to forward the link on to colleagues. A broadcast group means there will be no replies or conversation; the group will be used purely to broadcast important updates.

If you need to talk to someone at the ICB about urgent COVID-19 support or practice issues, including potential practice closures, please call: 0117 900 2540.

For feedback or suggestions about how we communicate with you, please email us here

NICE Guidelines

NICE have produced some rapid guidelines in response to COVID-19. We have listed the ones that are most relevant to Primary Care below:

COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community:

https://www.nice.org.uk/guidance/ng165

COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community:

https://www.nice.org.uk/guidance/NG163

COVID-19 rapid guideline: severe asthma:

https://www.nice.org.uk/guidance/NG166

COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD):

https://www.nice.org.uk/guidance/ng168



Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.